Lisata Therapeutics, Inc. (LSTA) Operating income 2015–2024
Lisata Therapeutics, Inc. (LSTA) annual operating income history from SEC filings — each fiscal year as reported.
-$18.2MFY2024 · since FY2015: -$29.5M → -$18.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.2M | +18.7% |
| FY2023 | -$22.4M | +12.8% |
| FY2022 | -$25.7M | +55.4% |
| FY2021 | -$57.6M | -98.3% |
| FY2020 | -$29.1M | -51.7% |
| FY2019 | -$19.1M | +4.7% |
| FY2018 | -$20.1M | -18.3% |
| FY2017 | -$17.0M | +38.4% |
| FY2016 | -$27.6M | +6.5% |
| FY2015 | -$29.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating marginLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →